Explanation
CD20
RituximabbindstoCD20.anantigenuocated onpre-Band matureB-ymphocytes.Thereceptor isthoughtto
mediateB-ceulvsisandapoptosis.Afterrtuximabtherapv.eves ofB-tvmphocytesappear suppressedfor
around6months.withevessowlvincreasinaafterthistime.Rituximabisusedtotreat rheumatoidarthritis
andnon-Hodakinstmphoma.Infusion reactions associated withcytokinereleaseoccur inupto15%of
oatientsreceivinartuximab.andthereforeadministrationundercosesupervision isreauired
@1MINENDOCRINE
